TNNI3 and diabetes mellitus: We evaluated the clinical performance of a dual-marker approach combining glucose, a universally available inexpensive biochemical signature of diabetes mellitus and the physiological stress response to AMI, with either hs-cTnT or hs-cTnI in the early diagnosis of NSTEMI.